GBIO Live signals | Maximize Profits with Getagraph.com

SELL 105288 min ago

@ $1.880

Issued: 13 Feb 2024 @ 15:30

Return: 54.26%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: -6.04 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Stats
Today's Volume	89 527.00
Average Volume	242 062
Market Cap	192.78M
EPS	$-0.530 ( 2024-03-07 )
Next earnings date	( $-0.360 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.480
ATR14	$0.00900 (0.31%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Stanton Matthew	Buy	1 674	Common Stock
2024-04-15	Stanton Matthew	Sell	492	Common Stock
2024-04-15	Stanton Matthew	Sell	1 674	Restricted Stock Units
2024-04-15	Samayoa Phillip	Buy	1 147	Common Stock
2024-04-15	Samayoa Phillip	Sell	337	Common Stock

INSIDER POWER
82.96
Last 100 transactions
Buy: 2 618 558 \| Sell: 231 211

Volume Correlation

Long: -0.05 (neutral)

Short: 0.85 (strong)

Signal:(50.038) Same movement expected

Generation Bio Co Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Generation Bio Co Correlation - Currency/Commodity

-0.88
( strong negative )

-0.87
( strong negative )

0.00
( neutral )

-0.79
( moderate negative )

-0.39
( neutral )

0.65
( moderate )

Generation Bio Co Financials

Annual	2023
Revenue:	$5.90M
Gross Profit:	$641 000 (10.86 %)
EPS:	$-1.960

FY	2023
Revenue:	$5.90M
Gross Profit:	$641 000 (10.86 %)
EPS:	$-1.960

FY	2022
Revenue:	$0
Gross Profit:	$-5.13M (0.00 %)
EPS:	$-2.27

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.10

Financial Reports:

No articles found.

Generation Bio Co

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.